Search Within

Susan E Prockop

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (117)
  2. Journal Article (43)
  3. Conference Paper (1)
  4. Review (1)
Groups
  1. Department of Medicine (162)
  2. GSK Faculty (162)
  3. Immunology Program Faculty (162)
  4. Pediatrics, Department of (162)
  5. Sloan Kettering Institute Faculty (162)
  6. Stem Cell Transplantation and Cellular Therapy Service (162)

More Groups

People
  1. Richard O'Reilly (160)
  2. Nancy Kernan (115)
  3. Farid Boulad (104)
  4. Andromachi Scaradavou (83)
  5. Esperanza Papadopoulos (54)
  6. Trudy Small (49)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (18)
  6. 2019 (13)

More Years

Publications
  1. Blood (64)
  2. Biology of Blood and Marrow Transplantation (49)
  3. Bone Marrow Transplantation (17)
  4. Cytotherapy (6)
  5. Transplantation and Cellular Therapy (5)
  6. Blood Advances (3)

More Publications

Publishers
  1. American Society of Hematology (67)
  2. Elsevier Inc. (55)
  3. Nature Publishing Group (17)
  4. Elsevier Science Ltd. (6)
  5. American Society of Clinical Oncology (3)
  6. Wiley Periodicals, Inc (3)

More Publishers

Results (162)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post transplant lymphoproliferative disorder
    Meeting Abstract

    Prockop, S. E.; Li, A.; Baiocchi, R.; Bunin, N. J.; Mahadeo, K. M.; Nemecek, E. R.; Nikiforow, S.; Reshef, R.; Tsai, D. E.; Navarro, W. H.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Genotype, phenotype and T cell counts at one year predict survival and long term immune reconstitution after transplantation in severe combined immune deficiency (SCID) - The Primary Immune Deficiency Treatment Consortium (PIDTC)
    Meeting Abstract

    Haddad, E.; Logan, B. R.; Griffith, L. M.; Buckley, R. H.; Parrott, R. E.; Dvorak, C. C.; Puck, J.; Prockop, S. E.; Kapoor, N.; Abdel-Azim, H.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post-transplant lymphoproliferative disorder
    Meeting Abstract

    Prockop, S.; Li, A.; Baiocchi, R. A.; Bunin, N.; Mahadeo, K. M.; Nemecek, E. R.; Nikiforow, S.; Reshef, R.; Tsai, D. E.; Navarro, W. H.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Gulati, N.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jackson, C.; Kernan, N.; Kung, A. L.; O'Reilly, R.; Prockop, S.; Ramaswamy, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Delayed onset subacute atypical hemolytic uremic syndrome (aHUS) post allogeneic stem cell transplantation (SCT)
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Scaradavou, A.; Allen, J.; Ruggiero, J.; Torok-Castanza, J.; Zakak, N.; O'Reilly, R. J.; Prockop, S. E.
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Radiation-free cytoreductive regimens and T-cell depleted allogeneic stem cell transplants (HSCT) for the treatment of 65 pediatric patients with hematologic malignancies
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Prockop, S. E.; Kobos, R.; Judge, A.; Cancio, M.; Curran, K. J.; Jackson, C. C.; Spitzer, B.; Koehne, G.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A chemotherapy-only regimen of busulfan, melphalan, and fludarabine, and rabbit antithymocyte globulin followed by allogeneic T-cell depleted hematopoietic stem cell transplantations for the treatment of myeloid malignancies
    Journal Article

    Spitzer, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Fuller, K.; Hilden, P. D.; Young, J. W.; Barker, J. N.; Koehne, G.; Perales, M. A.; Hsu, K. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save